NewsWHO approves China's Sinovac Covid jab

WHO approves China’s Sinovac Covid jab

-

Geneva, Switzerland: The World Health Organization on Tuesday approved the Sinovac Covid-19 vaccine for emergency use — the second Chinese jab to receive the WHO’s green light.

The UN health agency signed off on the two-dose vaccine, which is already being deployed in several countries around the world.

“WHO today validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use,” it said in a statement.

The move gives countries, funders, procuring agencies, and communities “assurance that it meets international standards for safety, efficacy, and manufacturing”.

Last month Sinopharm became the first Chinese vaccine to be approved by the WHO.

The organization has also given emergency use listing to vaccines being made by Pfizer/BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea, and the EU, which it counts separately.

WHO’s listing paves the way for countries worldwide to quickly approve and import a vaccine for distribution, especially those states without an international-standard regulator of their own.

It also opens the door for the jabs to enter the Covax global vaccine-sharing scheme, which aims to provide equitable access to doses around the world, particularly in poorer countries.

Currently, only AstraZeneca and some Pfizer jabs are flowing through the scheme.

“The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO’s assistant director-general for access to health products.

“We urge manufacturers to participate in the Covax facility, share their know-how and data, and contribute to bringing the pandemic under control.”

The Sinovac jab is already in use in 22 territories around the world, according to an AFP count.

Apart from China, the countries using Sinovac include Chile, Brazil, Indonesia, Mexico, Thailand, and Turkey.

The WHO’s Strategic Advisory Group of Experts on Immunisation have reviewed the jab and published their advice on its usage.

“WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said.

“Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 percent of those vaccinated and prevented severe Covid-19 and hospitalization in 100 percent of the studied population.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Antony Blinken to make the first visit to India

Washington, United States: US Secretary of State Antony Blinken will pay his first trip since taking office to India,...

Fans honor Amy Winehouse in London decade after her death

London, United Kingdom: Fans remembered British singer Amy Winehouse on Friday, paying tribute outside her former home in the...

Intrinsic: Alphabet launches new ‘moonshot’ for robotics software

San Francisco, United States: Google's parent Alphabet unveiled a new "moonshot" project to develop software for robotics that could...

Tajikistan ready to accept 100k Afghan refugees amid Taliban uprising

Dushanbe, Tajikistan: Tajikistan said Friday it was ready to accept up to 100,000 refugees from Afghanistan, where the Taliban has...

EU approves Moderna jab for ages 12 and up

The Hauge, Netherlands: The European medicines watchdog on Friday approved the use of Moderna's coronavirus vaccine for children aged...

Colombia says attack on president was planned from Venezuela

Bogota, Venezuela: The Colombian government claimed Thursday that a recent attack on President Ivan Duque's helicopter was planned from...

Must read

You might also likeRELATED
Recommended to you